Type to search

Evusheld Approved to Prevent COVID-19 in People Whose Immune Response is Poor | Pharmtech Focus
MHRA Approves Xevudy (sotrovimab), a COVID-19 Treatment Found to Cut Hospitalisation and Death by 79% | Pharmtech Focus
First Oral Antiviral for COVID-19, Lagevrio (molnupiravir), Approved by MHRA | Pharmtech Focus